ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
Case Medical Research
◽
10.31525/ct1-nct04241549
◽
2020
◽
Author(s):
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Intensive Treatment
◽
Newly Diagnosed
◽
Acute Myeloid
Download Full-text
Related Documents
Cited By
References
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Leukemia
◽
10.1038/s41375-018-0312-9
◽
2018
◽
Vol 33
(2)
◽
pp. 379-389
◽
Cited By ~ 145
Author(s):
Jorge E. Cortes
◽
Florian H. Heidel
◽
Andrzej Hellmann
◽
Walter Fiedler
◽
B. Douglas Smith
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Low Dose
◽
Newly Diagnosed
◽
Low Dose Cytarabine
◽
Acute Myeloid
Download Full-text
Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
Haematologica
◽
10.3324/haematol.2017.168732
◽
2017
◽
Vol 102
(10)
◽
pp. 1709-1717
◽
Cited By ~ 11
Author(s):
Naval Daver
◽
Hagop Kantarjian
◽
Guillermo Garcia-Manero
◽
Elias Jabbour
◽
Gautam Borthakur
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Older Patients
◽
Myeloid Leukemia
◽
Newly Diagnosed
◽
Acute Myeloid
Download Full-text
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome
Leukemia
◽
10.1038/leu.2015.244
◽
2015
◽
Vol 30
(2)
◽
pp. 268-273
◽
Cited By ~ 40
Author(s):
N Daver
◽
H Kantarjian
◽
F Ravandi
◽
E Estey
◽
X Wang
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Phase Ii
◽
Myeloid Leukemia
◽
Phase Ii Study
◽
Gemtuzumab Ozogamicin
◽
Newly Diagnosed
◽
Relapsed Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/s2152-2650(21)01811-5
◽
2021
◽
Vol 21
◽
pp. S350
Author(s):
Guillermo Garcia-Manero
◽
Andrew H. Wei
◽
Kimmo Porkka
◽
Steve Knapper
◽
Elie Traer
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Phase 1
◽
Hypomethylating Agents
◽
Newly Diagnosed
◽
Phase 1 Study
◽
Very High
◽
Acute Myeloid
Download Full-text
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome
Cancer
◽
10.1002/cncr.25575
◽
2010
◽
Vol 117
(6)
◽
pp. 1236-1244
◽
Cited By ~ 26
Author(s):
Elias Jabbour
◽
Hagop Kantarjian
◽
Farhad Ravandi
◽
Guillermo Garcia-Manero
◽
Zeev Estrov
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Phase 1
◽
Newly Diagnosed
◽
Farnesyltransferase Inhibitor
◽
Acute Myeloid
Download Full-text
Clofarabine plus cytarabine (ara-C) is an active induction regimen for newly diagnosed patients (pts) ≥ age 50 with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.6609
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 6609-6609
Author(s):
S. Faderl
◽
V. Gandhi
◽
F. Giles
◽
E. Estey
◽
G. Garcia-Manero
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Newly Diagnosed
◽
Induction Regimen
◽
Acute Myeloid
Download Full-text
Hospitalization rates in elderly, newly diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) patients treated with azacitidine.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.e18040
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. e18040-e18040
Author(s):
Masumi Ueda
◽
Divya Gupta
◽
Paolo Fabrizio Caimi
◽
Richard Creger
◽
Jane Little
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Newly Diagnosed
◽
Hospitalization Rates
◽
Acute Myeloid
Download Full-text
Clofarabine plus cytarabine (ara-C) is an active induction regimen for newly diagnosed patients (pts) ≥ age 50 with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.6609
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 6609-6609
Author(s):
S. Faderl
◽
V. Gandhi
◽
F. Giles
◽
E. Estey
◽
G. Garcia-Manero
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Newly Diagnosed
◽
Induction Regimen
◽
Acute Myeloid
Download Full-text
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Case Medical Research
◽
10.31525/ct1-nct04047641
◽
2019
◽
Author(s):
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Newly Diagnosed
◽
Refractory Acute Myeloid Leukemia
◽
Acute Myeloid
Download Full-text
Poster: MDS-420: Sabatolimab Plus Hypomethylating Agents (HMAs) in Patients with High-/Very High-risk Myelodysplastic Syndrome (HR/vHR-MDS) and Newly Diagnosed Acute Myeloid Leukemia (ND-AML): Subgroup Analysis of a Phase 1 Study
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/s2152-2650(21)01447-6
◽
2021
◽
Vol 21
◽
pp. S230
Author(s):
Guillermo Garcia-Manero
◽
Andrew H. Wei
◽
Kimmo Porkka
◽
Steve Knapper
◽
Elie Traer
◽
...
Keyword(s):
Acute Myeloid Leukemia
◽
High Risk
◽
Myelodysplastic Syndrome
◽
Myeloid Leukemia
◽
Phase 1
◽
Hypomethylating Agents
◽
Newly Diagnosed
◽
Phase 1 Study
◽
Very High
◽
Acute Myeloid
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close